Focal Interest
Focal Interest

Peripheral neuropathy

  1. Nine-month oral TB regimens showed durable three-year outcomes
    Nine-month all-oral TB regimens show 89.5% durable three-year cure rates but persistent linezolid neuropathy affects 22.6% of patients, raising safety concerns.